程青,四川大学华西医院特聘教授,博士生导师,华西医院胸部肿瘤研究所副所长,中国抗癌协会肿瘤标志专业委员会委员。专注于研究肿瘤异质性对精准医学的影响,运用基因组学,生物信息学和类器官培养等技术,开发肿瘤精准诊疗新途径,在Nat Genet, Nat Med, Eur Urol,Sci Transl Med等期刊发表多篇论文,受到Nat Genet和Eur Urol 在同期发表的专题社论高度肯定,被Nat Genet评价为开创世界个体化医学的新维度,6篇论文受到美国全国电视网NBC报导。曾任美国杜克大学癌症研究院资深研究员,外科系副教授,杜克医学院MD和PhD双博导。曾任多家美国纳斯达克上市公司的精准医学特聘顾问,并持有三项临床诊断的全球和美国专利。曾获四川省“天府峨眉”创新领军人才,美国国立健康研究院临床医学职业发展奖(NIH K12) 和卫生部科技进步一等奖
中国抗癌协会肿瘤标志专业委员会委员
1.论文
Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells. Cell Stem Cell, 31(8):1203,2024
Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages. Cell Reports Medicine, 5(4):101489,2024
Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer. Journal of Pathology, 260(1):43-55,2023
Pre-existing Castration-resistant Prostate Cancer-like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy. European Urology 81(5):446,2022
An age-independent gene signature for monitoring acute rejection in kidney transplantation. Theranostics 10(15):6977, 2020
ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer. OncoImmunology 9(1): 1758003, 2020
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer. Science Translational Medicine 11(521):eaax0428,2019
A novel integrative risk Index of Papillary Thyroid Cancer progression combining genomic alterations and patient-related demographic and clinical factors. Oncotarget 8(10): 16690, 2017
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. Science Translational Medicine 8:340ra73, 2016
Overexpression of the EMT Driver Brachyury in Breast Carcinomas: Association with Poor Prognosis. Journal of the National Cancer Institute 106: ju054, 2014
A signature of epithelial mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype. Breast Cancer Research 16:407, 2014
Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Research 14:R62, 2012
Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nature Medicine 17:1298, 2011
Epigenetic regulation of human r-glutamyl hydrolase activity in acute lymphoblastic leukemia cells. American Journal of Human Genetics 79:264, 2006
Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes. Nature Genetics 37:878, 2005
Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics. Journal of Clinical Investigation 115:110, 2005
2.专利
Biomarkers for the Identification of Aggressive Prostate Cancer and Methods of Treatment Thereof(WO 2023/122579 A2)
Gene Signatures for Monitoring Acute Rejection and Methods of Using Same(US 2021/0340269 A1)
Genotyping Assay to Predict Gamma Glutamyl Hydrolase (GGH) Activity (US 2012/0178087 A1)
研究生部公众号